Product Information

OXAZEPAM 30 MG CAPSULE is a generic product labeled by Leading Pharma, LLC, priced at $1.5124 per EA under NDC 69315091301. Its NADAC has been published 65 times since Aug 27, 2025.

FDA first approved this application on Mar 3, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OXAZEPAM 30 MG CAPSULE

OXAZEPAM
$1.5124per EA
DEA Schedule CIV

Strength

30 mg/1

NDC

69315091301

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

OXAZEPAM

Approval Type

Generic (ANDA)

FDA Application

ANDA218261

FDA Approved

3/3/2025

TE Code

AB

On Market Since

7/9/2025

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price Statistics

The NADAC for OXAZEPAM 30 MG CAPSULE has been published 65 times since Aug 27, 2025, and over the history we have for it it has risen 10.9%. The table below summarizes its recorded NADAC range and movement.

Current price$1.5124 per EA
All-time high$1.5124 (Nov 18, 2026)
All-time low$1.1218 (May 20, 2026)
52-week high$1.5124
52-week low$1.1218
Median price$1.2466
Average price$1.2527
Largest weekly change+9.3% (Sep 23, 2026)
Weeks tracked65
Tracking sinceAug 27, 2025

Price History

1W

+4.7%

1M

+12.1%

3M

+22.5%

6M

+34.8%

1Y

+16.0%

3Y

N/A

5Y

N/A

All

+10.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the OXAZEPAM market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OXAZEPAM 30 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for OXAZEPAM 30 MG CAPSULE, manufactured by Leading Pharma, LLC, is $1.5124 per EA (NDC 69315091301), effective Nov 18, 2026.

How has the price of OXAZEPAM 30 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for OXAZEPAM 30 MG CAPSULE has risen 10.9%. It has been tracked across 65 weekly CMS publications since Aug 27, 2025.

What are the highest and lowest recorded NADAC prices for OXAZEPAM 30 MG CAPSULE?

Since Aug 27, 2025, the NADAC for OXAZEPAM 30 MG CAPSULE has ranged from a low of $1.1218 (May 20, 2026) to a high of $1.5124 (Nov 18, 2026), with a median of $1.2466 per EA.

Are there cheaper alternatives to OXAZEPAM 30 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of OXAZEPAM 30 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures OXAZEPAM 30 MG CAPSULE?

OXAZEPAM 30 MG CAPSULE (NDC 69315091301) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.